AGP Limited

AGP Limited was incorporated in 1989.

AGP (Pvt.) Ltd. starts commercial operations

Enters into a joint venture with Eli Lilly Pakistan for their cephalosporin’s range

Signs an agreement with UCB Belgium to manufacture & market their products

Purchases Eli Lilly brand rights for Ceclor, Keflex, Kefzol & Nebcin in Pakistan

Enters into an agreement with OM Switzerland (now Vifor) to manufacture & market selected products

Purchase UCB brand rights for Rigix in Pakistan

Enters into a supply agreement with GSK Pakistan for manufacturing of UCB products

OBS led consortium (through a SPV Appollo Pharma) acquires AGP

AGP (Pvt,) Ltd. & AGP Healthcare (Pvt.) Ltd. merge into AGP Limited (Formerly Appollo Pharma)

Signs an agreement with Mylan for marketing & sales of their products in Pakistan

Enlistment on Pakistan Stock Exchange

Acquisition of Nutraceutical Plant

OBS AGP (Pvt.) Ltd. is incorporated as a SPV to acquire certain pharmaceutical Brands in Pakistan

OBS Pakistan (Pvt.) Ltd. is incorporated as a SPV to acquire certain pharmaceutical brands in Pakistan

Through OBS Pakistan, acquired 17 brands from Viatris Inc., which were commercialized in Pakistan under the brands previously owned by Pfizer Inc.

AGP Wins Silver Award at the SAFA Best Presented Annual Report Awards 2024

Publication of IFRS S1 and S2 aligned sustainability disclosures in AGP’s Annual Report 2025, structured across seven thematic sections: sustainability context and value chain, basis of preparation, SRROs, governance, strategy and resilience, risk management integration with ERM and metrics and targets.

Obtained marketing rights for the commercialization and promotion of globally recognized brands, Xanax and Viagra, expanding AGP’s specialty care portfolio.

Acquired marketing and distribution rights for selected STADA products, strengthening AGP’s commercial footprint.